Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Tiziana Life Sciences Ltd. (TLSA)

  • SEC News
  • Jan. 16, 2026, 12:43 UTC
  • 4
  • 0 comments

New Form 424B5 - Tiziana Life Sciences Ltd Filed: 2026-01-16 AccNo: 0001213900-26-004895 Size: 503 KB

Comment Full text

Arbutus Biopharma Corporation (ABUS)

  • SEC News
  • Jan. 16, 2026, 12:41 UTC
  • 1
  • 1 comments

(99% Neutral) Arbutus Biopharma Corporation (ABUS) Announces Update on Collaboration with Registrant

Comment Full text

Autonomix Medical Inc. (AMIX)

  • SEC News
  • Jan. 16, 2026, 12:30 UTC
  • 1
  • 1 comments

(99% Neutral) Autonomix Medical Inc. (AMIX) Files Form 8-K

Comment Full text

Adlai Nortye Ltd (ANL)

  • SEC News
  • Jan. 16, 2026, 12:05 UTC
  • 4
  • 0 comments

New Form SCHEDULE 13G - Adlai Nortye Ltd. Filed: 2026-01-16 AccNo: 0001213900-26-004890 Size: 7 KB

Comment Full text

Chemours Co (CC)

  • SEC News
  • Jan. 16, 2026, 11:49 UTC
  • 1
  • 1 comments

(99% Neutral) Chemours Co (CC) Announces Business Combination

Comment Full text

Cara Therapeutics (CARA)

  • SEC News
  • Jan. 16, 2026, 11:04 UTC
  • 1
  • 1 comments

(80% Positive) Cara Therapeutics (CARA) Announces Clinical Development Update

Comment Full text

NeuroBo Pharmaceuticals Inc. (NRBO)

  • SEC News
  • Jan. 16, 2026, 11:04 UTC
  • 6
  • 0 comments

New Form EFFECT - MetaVia Inc. Filed: 2026-01-15 AccNo: 9999999995-26-000181 Size: 1 KB

Comment Full text

Canopy Growth Corp (CGC)

  • SEC News
  • Jan. 16, 2026, 11:03 UTC
  • 8
  • 0 comments

New Form EFFECT - Canopy Growth Corp Filed: 2026-01-15 AccNo: 9999999995-26-000184 Size: 1 KB

Comment Full text

GlycoMimetics Inc. (GLYC)

  • SEC News
  • Jan. 16, 2026, 11:03 UTC
  • 6
  • 0 comments

New Form EFFECT - CRESCENT BIOPHARMA, INC. Filed: 2026-01-15 AccNo: 9999999995-26-000182 Size: 1 KB

Comment Full text

IHH Healthcare Berhad (Q0F)

  • SEC News
  • Jan. 16, 2026, 09:29 UTC
  • 6
  • 0 comments

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Comment Full text
  • Previous
  • 120
  • 121
  • 122
  • 123
  • 124
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189146)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124506)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin